delta-Tocopherol

δ-Tocopherol^[1]

IUPAC name (2R)-2,8-Dimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-6-chromanol
Identifiers
CAS number	119-13-1^Y
PubChem	92094
ChemSpider	83144^Y
UNII	JU84X1II0N^Y
ChEBI	CHEBI:47772^Y
Jmol-3D images	Image 1
SMILES Oc2cc(c1O[C@](CCc1c2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C
InChI InChI=1S/C27H46O2/c1-20(2)10-7-11-21(3)12-8-13-22(4)14-9-16-27(6)17-15-24-19-25(28)18-23(5)26(24)29-27/h18-22,28H,7-17H2,1-6H3/t21-,22-,27-/m1/s1^Y Key: GZIFEOYASATJEH-VHFRWLAGSA-N^Y InChI=1/C27H46O2/c1-20(2)10-7-11-21(3)12-8-13-22(4)14-9-16-27(6)17-15-24-19-25(28)18-23(5)26(24)29-27/h18-22,28H,7-17H2,1-6H3/t21-,22-,27-/m1/s1 Key: GZIFEOYASATJEH-VHFRWLAGBS
Properties
Molecular formula	C₂₇H₄₆O₂
Molar mass	402.65 g/mol
Y (verify) (what is: Y/N?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

δ-Tocopherol is one of the chemical compounds that is considered vitamin E. As a food additive, it has E number E309.

See the main article tocopherol for more information.

See also

References

^ (+)-δ-Tocopherol at Sigma-Aldrich

A	α-Carotene · β-Carotene · Retinol^# · Tretinoin

D	D₂ (Ergosterol, Ergocalciferol^#) · D₃ (7-Dehydrocholesterol, Previtamin D₃, Cholecalciferol, 25-hydroxycholecalciferol, Calcitriol (1,25-dihydroxycholecalciferol), Calcitroic acid) · D₄ (Dihydroergocalciferol) · D₅ · D analogues (Dihydrotachysterol, Calcipotriol, Tacalcitol, Paricalcitol)

E	Tocopherol (Alpha, Beta, Gamma, Delta) · Tocotrienol (Alpha, Beta, Gamma, Delta) · Tocofersolan

K	Naphthoquinone · Phylloquinone (K₁) · Menatetrenone (K₂) · Menadione (K₃) · Menadiol (K₄)

B	B₁ (Thiamine^#) · B₂ (Riboflavin^#) · B₃ (Niacin, Nicotinamide^#) · B₅ (Pantothenic acid, Dexpanthenol, Pantethine) · B₆ (Pyridoxine^#, Pyridoxal phosphate, Pyridoxamine) · B₇ (Biotin) · B₉ (Folic acid, Dihydrofolic acid, Folinic acid) · B₁₂ (Cyanocobalamin, Hydroxocobalamin, Methylcobalamin, Cobamamide) · Choline

C	Ascorbic acid^# · Dehydroascorbic acid

Combinations

^#WHO-EM. ^‡Withdrawn from market. Clinical trials: ^†Phase III. ^§Never to phase III

M: NUT

cof, enz, met

noco, nuvi, sysi/epon, met

drug(A8/11/12)